RV
Ravi Vital Kandisa
About Ravi Vital Kandisa
Data last updated:
Ravi Vital Kandisa is a Director at Scinexis Global Research Private Limited (since 2023), Director at Sero India Private Limited (since 2026) and Director at Hervita Private Limited (since 2025). The companies operate in Professional Services, Healthcare and Paper. The largest current company by reported revenue is Scinexis Global Research Private Limited at ₹12,712 (FY 2025). Earlier, Ravi Vital Kandisa was a Director at Bioweave Lifesciences Private Limited (2024–2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Scinexis Global Research Private Limited U72100AP2023PTC113344 | Director | 22 Dec 2023 | 2023 | ₹12,712 (FY 2025) | Active |
| Sero India Private Limited U86905AP2026FTC124434 | Director | 28 Feb 2026 | 2026 | Active | |
| Hervita Private Limited U72100AP2025PTC120367 | Director | 22 Jul 2025 | 2025 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Bioweave Lifesciences Private Limited U21006AP2024PTC114272 | Director | 20 Mar 2024 | 2024 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Ravi Vital Kandisa
| Name | DIN | Company | Designation |
|---|---|---|---|
| Vasudeva Rao Kandisa | 10436427 | Scinexis Global Research Private Limited | Director |
| Eileen Eldjarn | 11579125 | Sero India Private Limited | Director |
| Jens Stefan Nicolai Kernstock | 11579123 | Sero India Private Limited | Director |
| Knut Weydahl Eldjarn | 11579124 | Sero India Private Limited | Director |
| Bhavani Boddeda | 11206849 | Hervita Private Limited | Director |
| Neelima Nagalla | 11206851 | Hervita Private Limited | Director |
| Swathi Putta | 11206850 | Hervita Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ravi Vital Kandisa
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ravi Vital Kandisa
Ravi Vital Kandisa currently holds 3 directorships: Scinexis Global Research Private Limited (Director, since 22 Dec 2023, revenue ₹12,712 (FY 2025)); Sero India Private Limited (Director, since 28 Feb 2026); Hervita Private Limited (Director, since 22 Jul 2025).
Ravi Vital Kandisa was first appointed on 22 Dec 2023 as Director at Scinexis Global Research Private Limited. The most recent appointment on record is 28 Feb 2026 at Sero India Private Limited.
Ravi Vital Kandisa held 1 earlier board appointment: Bioweave Lifesciences Private Limited (Director, 20 Mar 2024 to 31 May 2025).
The current boards of Ravi Vital Kandisa's companies include Vasudeva Rao Kandisa (Scinexis Global Research Private Limited), Eileen Eldjarn (Sero India Private Limited), Jens Stefan Nicolai Kernstock (Sero India Private Limited), Knut Weydahl Eldjarn (Sero India Private Limited), Bhavani Boddeda (Hervita Private Limited), Neelima Nagalla (Hervita Private Limited), among others.